CVS Health Corp (CVS)
54.65
-1.16
(-2.08%)
USD |
NYSE |
Nov 04, 16:00
54.75
+0.10
(+0.18%)
After-Hours: 20:00
CVS Health Revenue (Quarterly): 91.23B for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 91.23B |
| March 31, 2024 | 88.44B |
| December 31, 2023 | 93.81B |
| September 30, 2023 | 89.76B |
| June 30, 2023 | 88.92B |
| March 31, 2023 | 85.28B |
| December 31, 2022 | 83.85B |
| September 30, 2022 | 81.16B |
| June 30, 2022 | 80.64B |
| March 31, 2022 | 76.83B |
| December 31, 2021 | 76.60B |
| September 30, 2021 | 73.79B |
| June 30, 2021 | 72.62B |
| March 31, 2021 | 69.10B |
| December 31, 2020 | 69.55B |
| September 30, 2020 | 67.06B |
| June 30, 2020 | 65.34B |
| March 31, 2020 | 66.76B |
| December 31, 2019 | 66.89B |
| September 30, 2019 | 64.81B |
| June 30, 2019 | 63.43B |
| March 31, 2019 | 61.65B |
| December 31, 2018 | 54.42B |
| September 30, 2018 | 47.49B |
| June 30, 2018 | 46.92B |
| Date | Value |
|---|---|
| March 31, 2018 | 45.74B |
| December 31, 2017 | 48.41B |
| September 30, 2017 | 46.18B |
| June 30, 2017 | 45.68B |
| March 31, 2017 | 44.51B |
| December 31, 2016 | 45.99B |
| September 30, 2016 | 44.62B |
| June 30, 2016 | 43.72B |
| March 31, 2016 | 43.22B |
| December 31, 2015 | 41.15B |
| September 30, 2015 | 38.64B |
| June 30, 2015 | 37.17B |
| March 31, 2015 | 36.33B |
| December 31, 2014 | 37.06B |
| September 30, 2014 | 35.02B |
| June 30, 2014 | 34.60B |
| March 31, 2014 | 32.69B |
| December 31, 2013 | 32.83B |
| September 30, 2013 | 31.93B |
| June 30, 2013 | 31.25B |
| March 31, 2013 | 30.75B |
| December 31, 2012 | 31.38B |
| September 30, 2012 | 30.23B |
| June 30, 2012 | 30.71B |
| March 31, 2012 | 30.80B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
65.34B
Minimum
Jun 2020
93.81B
Maximum
Dec 2023
78.30B
Average
76.83B
Median
Mar 2022
Revenue (Quarterly) Benchmarks
| Humana Inc | 29.40B |
| Amgen Inc | 8.503B |
| Walgreens Boots Alliance Inc | 37.55B |
| AirSculpt Technologies Inc | 51.00M |
| SeaStar Medical Holding Corp | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.77B |
| Total Expenses (Quarterly) | 88.19B |
| EPS Diluted (Quarterly) | 1.41 |
| Enterprise Value | 119.04B |
| Gross Profit Margin (Quarterly) | 14.67% |
| Profit Margin (Quarterly) | 1.94% |
| Earnings Yield | 10.28% |
| Operating Earnings Yield | 17.75% |
| Normalized Earnings Yield | 10.30 |